1. Home
  2. NKTX vs GPMT Comparison

NKTX vs GPMT Comparison

Compare NKTX & GPMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NKTX
  • GPMT
  • Stock Information
  • Founded
  • NKTX 2015
  • GPMT 2015
  • Country
  • NKTX United States
  • GPMT United States
  • Employees
  • NKTX N/A
  • GPMT N/A
  • Industry
  • NKTX Biotechnology: Pharmaceutical Preparations
  • GPMT Real Estate Investment Trusts
  • Sector
  • NKTX Health Care
  • GPMT Real Estate
  • Exchange
  • NKTX Nasdaq
  • GPMT Nasdaq
  • Market Cap
  • NKTX 170.8M
  • GPMT 148.4M
  • IPO Year
  • NKTX 2020
  • GPMT 2017
  • Fundamental
  • Price
  • NKTX $2.47
  • GPMT $2.97
  • Analyst Decision
  • NKTX Strong Buy
  • GPMT Buy
  • Analyst Count
  • NKTX 5
  • GPMT 5
  • Target Price
  • NKTX $15.20
  • GPMT $4.58
  • AVG Volume (30 Days)
  • NKTX 1.5M
  • GPMT 474.1K
  • Earning Date
  • NKTX 11-07-2024
  • GPMT 02-12-2025
  • Dividend Yield
  • NKTX N/A
  • GPMT 10.10%
  • EPS Growth
  • NKTX N/A
  • GPMT N/A
  • EPS
  • NKTX N/A
  • GPMT N/A
  • Revenue
  • NKTX N/A
  • GPMT N/A
  • Revenue This Year
  • NKTX N/A
  • GPMT N/A
  • Revenue Next Year
  • NKTX N/A
  • GPMT N/A
  • P/E Ratio
  • NKTX N/A
  • GPMT N/A
  • Revenue Growth
  • NKTX N/A
  • GPMT N/A
  • 52 Week Low
  • NKTX $2.08
  • GPMT $2.46
  • 52 Week High
  • NKTX $16.24
  • GPMT $6.13
  • Technical
  • Relative Strength Index (RSI)
  • NKTX 50.49
  • GPMT 51.42
  • Support Level
  • NKTX $2.19
  • GPMT $2.61
  • Resistance Level
  • NKTX $2.70
  • GPMT $2.99
  • Average True Range (ATR)
  • NKTX 0.15
  • GPMT 0.12
  • MACD
  • NKTX 0.03
  • GPMT 0.03
  • Stochastic Oscillator
  • NKTX 54.90
  • GPMT 87.80

About NKTX Nkarta Inc.

Nkarta Inc is a biopharmaceutical company engaged in developing engineered natural killer (NK) cells to treat cancer and autoimmune diseases. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer. The Company's operations are based in South San Francisco, California.

About GPMT Granite Point Mortgage Trust Inc.

Granite Point Mortgage Trust Inc focuses on directly originating, investing in, and managing senior floating rate commercial mortgage loans and other debt and debt-like commercial real estate investments. The company constructs its investment portfolio on a loan-by-loan basis, emphasizing rigorous credit underwriting, selectivity, and diversification, and assesses each investment from a fundamental value perspective relative to other opportunities available in the market. It typically provides intermediate-term bridge or transitional financing for a variety of purposes, including acquisitions, recapitalizations, refinancing, and a range of business plans, including lease-up, renovation, repositioning, and repurposing of the property.

Share on Social Networks: